LOS ANGELES, CA, January 11, 2022 / 24-7PressRelease / – Plasmapp Co., Ltd. (CEO Yoo-bong Lim) is a plasma company established in 2015 in the laboratory of KAIST. With their original plasma technology, it holds 140 patents and was selected as a “Preliminary Unicorn” and was included in the Top 100 Small Business Startups by the Ministry of SMEs and Startups. In addition to attracting 46 billion won in investment, it was recently recognized for its technological prowess by receiving an A rating in the special cases assessment for the technology list. It currently exports to more than 50 countries around the world, reaching the “top $ 3 million in exports” in 2021. In November 2021, it was the first mini plasma sterilizer to be approved by the FDA.
Existing medical sterilizers had to be manufactured in high capacity because they took a long time to sterilize. This led to the manufacture of expensive equipment, and there were limitations as it could not be used in small and medium-sized medical facilities (at the clinic level). Plasmapp has caught the attention of those small and medium-sized medical institutions and hospitals that have high frequency of surgeries by introducing low-capacity, high-speed plasma sterilization technology with low thermal damage.
In addition, by introducing plasma technology to regenerate and activate medical implants and launching a product that improves osseointegration performance by sterilizing and removing impurities in one minute, Plasmapp is expected to consolidate its position in a market that requires performance. high surface treatment.
Direct Plasma Sterilization (Medi-DSP) is a sterilization technology that can extend the life of medical devices by minimizing damage using low temperature sterilization methods with plasma. Existing sterilizers have limitations in terms of damage to medical devices due to high temperatures and high pressure.
Bio-RAP (Regenerative Plasma Activation) is a biological regeneration and activation technology that can dramatically shorten the stabilization period of surgery by removing hydrocarbons and impurities from the implant surface and improving hydrophilicity. and protein absorption.
STERLINK’s sterilization solution is the world’s first direct injection sterilizer that achieves sterilization performance in at least 7 minutes, which is 10 times faster than bag-type sterilizers. With impermeable film, aseptic preservation is improved by automatically sealing after sterilization, and complete infection management is possible by intuitively checking asepsis (infection state) in a vacuum state.
The ACTILINK regeneration / activation solution differs from the conventional UV method, which has low permeability, and from the argon plasma method, which requires removal of the packaging. It regenerates and activates the implants by eliminating the hydrocarbons and impurities generated by the plasma treatment in the minute preceding the operation.
Meanwhile, Plasmapp has obtained FDA certification for the first time for its mini plasma sterilizer which is expected to enter the US market. He also discusses ODM contracts with global medical device manufacturers in the United States, Europe and Japan, and continuously prepares to enter overseas markets. Based on this, Plasmapp expressed their ambition to move from a preliminary unicorn to a global unicorn.
Hot Spot MIK (MADE IN KOREA) online exhibition is expected to be held regularly according to the field, target market and participating institutions, and it will be presented as a new kind of online business by transforming know-how and values of participating companies according to the trend. Businesses wishing to participate can apply and apply through the Marketing Support Projects of Local Government Support Institutions. Refer to the establishments for more information.
Press release service and press release distribution provided by http://www.24-7pressrelease.com